Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

BioProcess International
September 22-25, 2026 as part of Biotech Week Boston
Hynes Convention CenterBoston, USA
Book Now
Menu
Book
Key Sessions
Andrea Little
KEYNOTE: Engineering ADC Success from the Start: The Critical Role of Cell Culture
Pfizer
Jared Auclair, PhD
KEYNOTE: Biopharmaceutical Characterization in the Age of Artificial Intelligence: From Data to Decision
Northeastern University
Nelly Viseux
Keynote: Journey from R&D to Clinical Manufacturing
Regeneron
Robert Hofmeister
Keynote: Programming Immunity In Vivo: Targeted RNA–LNP Platforms for Precision CAR Engineering
CREATE Medicines
keyboard_arrow_right

Agenda September 25, 2026: Main Conference Day Three - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Agenda September 25, 2026: Main Conference Day Three - ET (Eastern Time, GMT-05:00)
search
Showing 1 of 1 Streams
8:20am - 8:50am
Registration and Morning Coffee
Showing 10 of 10 Streams
8:50am - 9:00am
Chairperson Remarks
  • Kent Rapp - CEO, Biolinco
9:00am - 10:00am
Fireside Chat: New Modalities, Old Playbook: Are Multispecifics and Gene Therapy Cell Lines Stuck in mAb Thinking?
  • Yifeng Xu - Principal Scientist, Pfizer
  • Duncan McVey, Ph.D. - Senior Scientific Director, Bristol-Myers Squibb
  • Maximilian Hoerner - Head of Optogenetics, Prolific Machines
  • Thomas Kelly - Director, Cell Engineering & Analytical Sciences, Johnson & Johnson Innovative Medicine
10:00am - 10:30am
From Bottleneck to Advantage: A High-Throughput Approach to Optimizing the Secretory Pathway
  • Tero-Pekka Alastalo - CEO, Avenue Biosciences
8:50am - 9:00am
Chairperson's Remarks
  • Aravindan Rajendran - Associate Research Fellow - Group Leader, Pfizer
9:00am - 9:30am
The Age of Automation: Successful Design, Development, and Deployment of a Fully Automated, Bench-Scale Bioreactor Platform
  • Brandon Veres - Staff Engineer, Regeneron
9:30am - 10:00am
KEYNOTE: Engineering ADC Success from the Start: The Critical Role of Cell Culture
  • Andrea Little - Associate Research Fellow – Cell Culture, Pfizer
10:00am - 10:30am
Shear Protectant Strategies in Perfusion: Understanding Poloxamer 188 Retention
  • Damien Bellos - Technical Manager, BASF
8:50am - 9:00am
Chair
  • Medine Ayhan - Senior Scientist, Downstream Process Development, Amgen
9:00am - 9:30am
Building a Polishing Chromatography Toolbox for AAV Manufacturing
  • Garima Thakur - Staff Engineer, Regeneron Pharmaceuticals
9:30am - 10:00am
A Case Study
  • Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, NC State University, North Carolina State University
10:00am - 10:30am
Reducing Protein A Capture Costs in Commercial mAb Manufacturing: Two Technical Pathways
  • Aaron Moulin - Global Technical Consultant, Bioprocessing, Ecolab Life Sciences
8:50am - 9:00am
Chair
  • Michael O'Connor - Principal Scientist, Pilot Plant Network & External Manufacturing, Bristol-Myers Squibb
9:00am - 9:30am
KEYNOTE: Biopharmaceutical Characterization in the Age of Artificial Intelligence: From Data to Decision
  • Jared Auclair, PhD - Dean Northeastern University College of Professional Studies, Director of Bioinnovation, Northeastern University
9:30am - 10:00am
Accelerating Biologics Process Analytics through End-to-End Sample Testing Automation
  • Pernesso Geffrard - Scientist, Bristol-Myers Squibb
10:00am - 10:30am
From Initial Screening to GMP: Accelerated Downstream Process Development for Complex Biologics
  • Samuel Claesson - Associate Scientist, Bionova Scientific
8:50am - 9:00am
Chair
  • Vanecia Harrison-Sanders - Director of Graduate Co-op, Northeastern University
  • Mary McLaughlin - Associate Director of Partnership Development, Northeastern University
9:00am - 9:30am
Critical Quality Attributes in Modern Biopharmaceutical Development: From Established mAbs to Emerging Modalities
  • Elisabeth Krug - Executive Director, Eli Lilly & Company
9:30am - 10:00am
Forced degradation studies, understanding molecule liabilities and de-risking manufacturing during early-stage development
  • Gregory Zarbis-Papastoitsis, Ph.D - Chief Process and Manufacturing Officer, Ankyra
10:00am - 10:30am
Modernizing Bioprocess Approaches to Enhance Safety and Consistency
  • Hui Yu, PhD - Field Application Development Director, ACROBiosystems
Showing 3 of 3 Streams
10:30am - 11:15am
Morning Break in the Exhibit Hall and Poster Viewing
10:30am - 10:40am
Trehalose supplementation enhances antibody production during the CHO cell culture process
  • Riko Yamaguchi - Associate Scientist, Nagase Viita Co., Ltd.
10:40am - 11:15am
10:40 – 11:20 PANEL: What is AI Ready Data?
  • James Colley - Senior Phorum Director, BioPhorum IT, Digital and Data, BioPhorum
  • Martin Kockx - Principal Manufacturing Systems Engineer, Vertex Pharmaceuticals
  • Bharath Sundararaman - Senior Director, Digital Manufacturing, Pfizer
10:45am - 11:15am
CGT Meet the Speakers

Go beyond the podium and engage in meaningful dialogue with the researchers, clinicians, and industry leaders who are advancing the field.

Showing 10 of 10 Streams
11:15am - 11:45am
Right-First-Time Cell Line Development: Speed, Productivity, and Quality by Design
  • Duncan McVey, Ph.D. - Senior Scientific Director, Bristol-Myers Squibb
11:45am - 12:15pm
Rebuilding CLD Without Legacy Constraints: A Strategy- and Data-Driven Case Study
  • Sowmya Balasubramanian - Associate Director, Cell Line Development, Gilead Sciences
12:15pm - 12:45pm
Rapid, Purpose-Built CHO Hosts: Genome-Engineered CleanCut GS Cell Lines Addressing HCP Burden, Culture Longevity, Glycan Risk, and Productivity
  • Corey Brizzee, PhD - Director of Gene Editing, Demeetra
11:15am - 11:45am
Upstream Matters for ADCs: Locking High-Performance Upstream to Simplify Downstream
  • Xiaolin Zhang - Associate Principal Scientist, Merck & Co
11:45am - 12:15pm
A Solubility‑Enabled Tyrosine Delivery Strategy for Robust Biologics Manufacturing
  • Utsavi Sevak - Senior Associate Scientist, Bioprocess Development, Bristol-Myers Squibb
12:15pm - 12:45pm
Purity that Powers Performance: Enabling Consistent Bioprocessing Outcomes with High-Quality Excipients
  • Garima Sinha - Research and Technology Manager, Croda Pharma
11:15am - 11:45am
Fireside Chat: Platform vs. Bespoke: How to Design Robust, Scalable Purification Solutions for Standard mAbs and Novel, Complex Therapies
  • James Pullen - Senior Director of Downstream Process Development, FUJIFILM Biotechnologies
  • Millie Hoe - Life Science Reporter, Bioxconomy, Informa Connect
11:45am - 12:15pm
Bispecific DSP: Double the Trouble or Twice as Nice
  • Gavin Wild - Head of Early Process Sciences, UCB
12:15pm - 12:45pm
Advanced Integration and Process Intensification of a Continuous Downstream Purification Platform for Monoclonal Antibody Production
  • Abbie Breton - Manager of Application Development, Tosoh
11:15am - 11:45am
Artificial Intelligence Applications in the Modeling and Analysis of Biopharmaceutical Factory Digital Twins
  • Joseph Pekny - Professor, Chemical Engineering, Purdue University
  • Sumitava De - Bioprocess Modeling Engineer, Sanofi
11:45am - 12:15pm
Fireside Chat: From Pilot to Plant: What It Really Takes To Scale Digital Biomanufacturing
  • Tiffany D Rau, PhD - Principal Consultant BioPharma Technical Consulting and Rau Consulting, Adjunct Professor Biochemistry and Cell Biology, University College Cork, Ireland
  • Jon Stratton - Sales and Business Development Manager, SciY
  • Dan Stanton - Trade Media Relations Expert, Sartorius
12:15pm - 12:45pm
Scaling AI in CMC with Structured Data
  • Arielle Mann - Science & Technology Manager, Genedata Inc.
11:15am - 11:45am
A Practical Workflow for Assessing Glass Vial Performance in Drug Product Development
  • Manasi Nawathe - Scientist I, Bora Biologics
11:45am - 12:15pm
Agility and Robustness by Design: Rethinking the Process Validation Lifecycle
  • Jian Ren, Ph.D. - Principal Scientist, AbbVie
12:15pm - 12:45pm
Advances in Ion Exchange and Multimodal Chromatography Resins for Monoclonal Antibody Polishing
  • Hans Johansson - General Manager, Sunresin
Showing 3 of 3 Streams
12:45pm - 2:00pm
Lunch
12:45pm - 1:20pm
12:40 – 13:20 PANEL: Women in Bioprocessing: Leadership, Innovation, and Career Growth in Biotech (Continued)
  • Pamela Klecki - President, Association for Women in Science, Massachusetts (Boston) Chapter
  • Amy Shaw - Senior Director, Process Development, Genetix Biotherapeutics
  • Deniz Temel, PhD - Director, CMC & Analytical Development, Third Arc Bio
  • Janet Chung - CMC Project Manager, Rocket Pharmaceuticals
  • Melanie Matheu - Co-Founder and CSO, Lyric Bio
1:20pm - 1:30pm
Sedimentation Velocity Analytical Ultracentrifugation Evaluation of Cellular EV Subpopulations Isolated Using Rate Zonal Density Gradient Ultracentrifugation and characterized on the CytoFLEX nano Flow Cytometer
  • Lutz Ehrhardt - Senior Manager Field Marketing Centrifugation, Beckman Coulter Life Sciences
1:00pm - 1:10pmLive Lab
Collect Headsets
1:10pm - 1:20pmLive Lab
Live Lab Millipore Sigma
1:20pm - 1:30pmLive Lab
Live Lab: Datahow
1:30pm - 1:40pmLive Lab
Live Lab: Boston Institute of Biotechnology
1:40pm - 1:50pmLive Lab
Live Lab: GBI Biomanufacturing
Showing 7 of 7 Streams
2:00pm - 2:30pm
Genetic Characterization in Cell Line Development: What Matters Most in Practice Today
  • William Stanney Ph.D. - Senior Scientist, Abbvie
2:30pm - 3:30pm
PANEL DISCUSSION: Precision Cell Line Engineering for Biologics: Focused Innovations and Applications
  • Stefan Schmidt - Advisor, Optigenomics Ltd
  • Andy Racher, Ph.D. - co-Chief Executive Officer, SynGenSys
  • Laura Greenfield - Bioprocessing Expert, Pfizer
  • Jacqualyn Schulman, Ph.D. - Principal Scientist, Cell Line Development & ‘Omics Biologics Development, Bristol-Myers Squibb
2:00pm - 2:30pm
From Capping to Conjugation: Cell Culture Levers That Shape Cysteine Availability and ADC DAR
  • Jin Xu - Senior Scientist, AstraZeneca
2:30pm - 3:30pm
PANEL DISCUSSION: Shared Pain Points Between Upstream and Downstream Processes
  • Ken Lee - Director, AstraZeneca
  • Yi Wang - Senior Scientist, Merck
  • Renée Hart - President & Chief Business Officer, LumaCyte
  • Smita Shankar - Founder & CEO, CUVIA
  • Timothy Keefe - Leading CMC strategy as Independent CMC Consultant, Independent
  • Ayman Ismail - Principal Consultant, Ayman Ismail Consulting
2:00pm - 2:30pm
Guiding Robocolumn Use in Process Development: FAQs, Limitations, and Fit-for-Purpose Scope
  • Skaison Kim - Sr. Staff Engineer, Process Development, Takeda
2:30pm - 3:30pm
Room 312: PANEL DISCUSSION: Shared Pain Points Between Upstream and Downstream Processes
  • Ken Lee - Director, AstraZeneca
  • Yi Wang - Senior Scientist, Merck
  • Renée Hart - President & Chief Business Officer, LumaCyte
  • Smita Shankar - Founder & CEO, CUVIA
  • Timothy Keefe - Leading CMC strategy as Independent CMC Consultant, Independent
  • Ayman Ismail - Principal Consultant, Ayman Ismail Consulting
2:00pm - 2:30pm
From Copilots to Agents: A GMP-Ready Framework for AI Adoption across CMC and Bioprocessing
  • Alexa Kopf - Consultant, BioProcess Technology Group (BDO) and Founder, LabScale AI
2:30pm - 3:30pm
PANEL DISCUSSION: The Future of Facilities: Enabling Autonomous Bioprocessing
  • Udayanath Aich, Ph.D. - Director, Bristol Myers Squibb
  • Mihir Shukla - Founder & CEO, Biopharma Consulting Solutions
  • Alexa Kopf - Consultant, BioProcess Technology Group (BDO) and Founder, LabScale AI
  • Kat Kozyrytska - AI & Automation Technology Strategy, Advisory
  • Gemma McCarthy - Senior Engineer II, MSAT, Takeda
  • Jordan Croteau - Head, Intelligent Operations, Stellix
  • Jin Kim - Executive Director of Global Business Development, Enzene
2:00pm - 2:30pm
Unlocking the Regenerative Potential of Exosomes: From Bioprocess Development to Advanced Drug Delivery Platform
  • Tali Kizhner - RD Director, NurExone Biologic
2:30pm - 3:00pm
Accelerating Site Readiness: Risk-Tiered Facility CQV Strategy for Qualification from Development-to-Commercial Continuum
  • Gurinderpal Singh - Director, Quality Operations R & D, GSK
3:00pm - 3:30pm
PANEL DISCUSSION: Strategies to Future-Proof Manufacturing Processes for Large-Scale Production
  • Bharat Dixit - Chief Technology Officer, ClearB Therapeutics
  • Tiffany D Rau, PhD - Principal Consultant BioPharma Technical Consulting and Rau Consulting, Adjunct Professor Biochemistry and Cell Biology, University College Cork, Ireland
  • Deniz Temel, PhD - Director, CMC & Analytical Development, Third Arc Bio
  • Linda Klauss, PhD - Senior Field Application Scientist, Gyros Protein Technologies
  • Ravi Chari - Associate Director (Analytical Development), Boston Institute of Biotechnology
Showing 1 of 1 Streams
3:30pm - 3:35pm
Close of Conference
Agenda September 24, 2026: Main Conference Day Two
Filter
Streams
Choose Day